{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BxPC3", "Oxalis obtriangulata", "anti-cancer effect", "pancreatic cancer"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32422890", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "14"}], "Language": ["eng"], "ELocationID": ["2301", "10.3390/molecules25102301"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "10", "PubDate": {"Year": "2020", "Month": "May", "Day": "14"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Anti-Cancer Potential of <i>Oxialis obtriangulata</i> in Pancreatic Cancer Cell through Regulation of the ERK/Src/STAT3-Mediated Pathway.", "Abstract": {"AbstractText": ["As a plant medicine, <i>Oxalidaceae</i> has been used to treat various diseases in Korea. However, there is little data on the anti-cancer efficacy of <i>Oxalidaceae</i>, particularly <i>O. obtriangulata</i>. This study aimed to investigate the anti-cancer effect of <i>O. obtriangulata</i> methanol extract (OOE) and its regulatory actions on pancreatic carcinoma. OOE showed anti-proliferative effects and induced cell death in the colony formation and cell viability assays, respectively. The Fluorescence-activated cell sorting (FACS) data confirmed that OOE significantly induced cell cycle accumulation at the G2/M phase and apoptotic effects. Additionally, OOE inhibited the activated ERK (extracellular-signal-regulated kinase)/Src (Proto-oncogene tyrosine-protein kinase Src)/STAT3 (signal transducers and activators of transcription 3) pathways including nuclear translocation of STAT3. Furthermore, suppression of Ki67, PARP(Poly ADP-ribose polymerase), caspase-3, P27(Cyclin-dependent kinase inhibitor 1B), and c-Myc as well as the STAT3 target genes CDK(cyclin-dependent kinase)1, CDK2, Cyclin B1, VEGF-1(vascular endothelial growth factor-1), MMP-9(Matrix metallopeptidase 9), and Survivin by OOE was observed in BxPC3. We speculate that these molecular actions might support an anti-cancer effect of OOE. In this study, we demonstrated that OOE may be a promising anti-cancer material and may serve as a natural therapy and alternative remedy for pancreatic cancer treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "An", "ForeName": "Eun-Jin", "Initials": "EJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Kim", "ForeName": "Yumi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Lee", "ForeName": "Seung-Hyeon", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Ko", "ForeName": "Hyun Min", "Initials": "HM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}], "LastName": "Chung", "ForeName": "Won-Seok", "Initials": "WS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "College of Korean Medicine and College of Pharmacy, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}], "LastName": "Jang", "ForeName": "Hyeung-Jin", "Initials": "HJ"}], "GrantList": [{"GrantID": "2017R1A2B4003422", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "2017R1D1A1B03034345", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "CCNB1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin B1"}, {"RegistryNumber": "0", "NameOfSubstance": "MAS1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Mas"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT3 Transcription Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "VEGFA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factor A"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "Proto-Oncogene Proteins pp60(c-src)"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "MAPK1 protein, human"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "MAPK3 protein, human"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Mitogen-Activated Protein Kinase 1"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Mitogen-Activated Protein Kinase 3"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "MMP9 protein, human"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "Matrix Metalloproteinase 9"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cyclin B1"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Magnoliopsida"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Matrix Metalloproteinase 9"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinase 1"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinase 3"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Pancreas"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Proto-Oncogene Mas"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Proteins pp60(c-src)"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "STAT3 Transcription Factor"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Vascular Endothelial Growth Factor A"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kamisawa T., Wood L.D., Itoi T., Takaori K. Pancreatic cancer. Lancet. 2016;388:73\u201385. doi: 10.1016/S0140-6736(16)00141-0.", "ArticleIdList": ["10.1016/S0140-6736(16)00141-0", "26830752"]}, {"Citation": "Adamska A., Domenichini A., Falasca M. Pancreatic ductal adenocarcinoma: Current and evolving therapies. Int. J. Mol.Sci. 2017;18:1338. doi: 10.3390/ijms18071338.", "ArticleIdList": ["10.3390/ijms18071338", "PMC5535831", "28640192"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Johnston P.A., Grandis J.R. STAT3 signaling: Anticancer strategies and challenges. Mol. Interv. 2011;11:18. doi: 10.1124/mi.11.1.4.", "ArticleIdList": ["10.1124/mi.11.1.4", "PMC3063716", "21441118"]}, {"Citation": "Daddacha W.B., Koyen A.E., Schlafstein A.J., David S.Y. Role of STAT3 in Pancreatic Cancer: A Target for Therapy. In: Nagaraju G.P., Bramhachari P.V., editors. Role of Transcription Factors in Gastrointestinal Malignancies. Springer; New York, NY, USA: 2017. pp. 341\u2013350."}, {"Citation": "Jain D., Ahmad T., Cairo M., Aronow W. Cardiotoxicity of cancer chemotherapy: Identification, prevention and treatment. Ann. Transl. Med. 2017;5:382. doi: 10.21037/atm.2017.06.35.", "ArticleIdList": ["10.21037/atm.2017.06.35", "PMC5599271", "28936442"]}, {"Citation": "Greenwell M., Rahman P. Medicinal plants: Their use in anticancer treatment. Int. J. Pharm. Sci. 2015;6:4103.", "ArticleIdList": ["PMC4650206", "26594645"]}, {"Citation": "Wang H., Oo Khor T., Shu L., Su Z.-Y., Fuentes F., Lee J.-H., Tony Kong A.-N. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med. Chem. 2012;12:1281\u20131305. doi: 10.2174/187152012803833026.", "ArticleIdList": ["10.2174/187152012803833026", "PMC4017674", "22583408"]}, {"Citation": "Karunanithi S. Pharmacognostical and Phytochemical Studies on Leaves of Oxalis Corniculata Linn.  [(accessed on 12 May 2020)];2016  Available online:  https://www.semanticscholar.org/paper/Pharmacognostical-and-phytochemical-studies-on-of-Karunanithi-Rajkishore/73381687cf1ead25b96e69c65a515d9b4f4695be."}, {"Citation": "Lee K.M., Lee G.S., Shim H., Oh S.K., Park I.H., Yim D., Kang T.J. Anti-Acne Effects of Herbal Complex in Acne Vulgaris Mouse Model. Korean J. Pharm. 2012;43:323\u2013327."}, {"Citation": "Haura E.B. SRC and STAT pathways. J. Thorac. Oncol. 2006;1:403\u2013405. doi: 10.1097/01243894-200606000-00003.", "ArticleIdList": ["10.1097/01243894-200606000-00003", "17409890"]}, {"Citation": "Siveen K.S., Sikka S., Surana R., Dai X., Zhang J., Kumar A.P., Tan B.K., Sethi G., Bishayee A. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. BBA Rev. Cancer. 2014;1845:136\u2013154. doi: 10.1016/j.bbcan.2013.12.005.", "ArticleIdList": ["10.1016/j.bbcan.2013.12.005", "24388873"]}, {"Citation": "R\u00e9b\u00e9 C., V\u00e9gran F., Berger H., Ghiringhelli F. STAT3 activation: A key factor in tumor immunoescape. Jak Stat. 2013;2:e23010.", "ArticleIdList": ["PMC3670267", "24058791"]}, {"Citation": "Sakaguchi M., Oka M., Iwasaki T., Fukami Y., Nishigori C. Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells. J. Invest. Derm. 2012;132:1877\u20131885. doi: 10.1038/jid.2012.45.", "ArticleIdList": ["10.1038/jid.2012.45", "22418867"]}, {"Citation": "Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and-independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell Biol. 1997;17:6508\u20136516. doi: 10.1128/MCB.17.11.6508.", "ArticleIdList": ["10.1128/MCB.17.11.6508", "PMC232504", "9343414"]}, {"Citation": "Kohno M., Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 2006;38:200\u2013211. doi: 10.1080/07853890600551037.", "ArticleIdList": ["10.1080/07853890600551037", "16720434"]}, {"Citation": "Zheng C., Jiao X., Jiang Y., Sun S. ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. J. Int. Med. Res. 2013;41:300\u2013306. doi: 10.1177/0300060512474128.", "ArticleIdList": ["10.1177/0300060512474128", "23569008"]}, {"Citation": "Wang M., Lu X., Dong X., Hao F., Liu Z., Ni G., Chen D. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression. World J. Surg. Oncol. 2015;13:66. doi: 10.1186/s12957-015-0451-7.", "ArticleIdList": ["10.1186/s12957-015-0451-7", "PMC4337256", "25880226"]}, {"Citation": "DiPaola R.S. To arrest or not to G2-M Cell-cycle arrest: Commentary re: AK Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis. Clin. Cancer Res. 2002;8:3311\u20133314.", "ArticleIdList": ["12429616"]}, {"Citation": "Hu B., Mitra J., van den Heuvel S., Enders G.H. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell Biol. 2001;21:2755\u20132766. doi: 10.1128/MCB.21.8.2755-2766.2001.", "ArticleIdList": ["10.1128/MCB.21.8.2755-2766.2001", "PMC86906", "11283255"]}, {"Citation": "Gabay M., Li Y., Felsher D.W. MYC activation is a hallmark of cancer initiation and maintenance. CSH Perspect. Med. 2014;4:a014241. doi: 10.1101/cshperspect.a014241.", "ArticleIdList": ["10.1101/cshperspect.a014241", "PMC4031954", "24890832"]}, {"Citation": "Payne S.R., Zhang S., Tsuchiya K., Moser R., Gurley K.E., Longton G., deboer J., Kemp C.J. p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol. Cell Biol. 2008;28:258\u2013268. doi: 10.1128/MCB.01536-07.", "ArticleIdList": ["10.1128/MCB.01536-07", "PMC2223298", "17954563"]}, {"Citation": "Yang W., Shen J., Wu M., Arsura M., FitzGerald M., Suldan Z., Kim D.W., Hofmann C.S., Pianetti S., Romieu-Mourez R. Repression of transcription of the p27 Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene. 2001;20:1688\u20131702. doi: 10.1038/sj.onc.1204245.", "ArticleIdList": ["10.1038/sj.onc.1204245", "11313917"]}, {"Citation": "Westphal S., Kalthoff H. Apoptosis: Targets in pancreatic cancer. Mol. Cancer. 2003;2:6. doi: 10.1186/1476-4598-2-6.", "ArticleIdList": ["10.1186/1476-4598-2-6", "PMC149420", "12605713"]}, {"Citation": "Chen G., Shi Y., Zhang Y., Sun J. CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway. Oncotargets. 2017;10:5783. doi: 10.2147/OTT.S150678.", "ArticleIdList": ["10.2147/OTT.S150678", "PMC5722018", "29255366"]}, {"Citation": "Hwang S.T., Kim C., Lee J.H., Chinnathambi A., Alharbi S.A., Shair O.H., Sethi G., Ahn K.S. Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine. 2019;59:152907. doi: 10.1016/j.phymed.2019.152907.", "ArticleIdList": ["10.1016/j.phymed.2019.152907", "30981183"]}, {"Citation": "Kim Y., Kim K.-H., Lee I.-S., Park J.Y., Na Y.-C., Chung W.-S., Jang H.-J. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells. Phytomedicine. 2019;56:48\u201356. doi: 10.1016/j.phymed.2018.08.006.", "ArticleIdList": ["10.1016/j.phymed.2018.08.006", "30668353"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "25"}, {"Year": "2020", "Month": "5", "Day": "7"}, {"Year": "2020", "Month": "5", "Day": "12"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["32422890", "PMC7288118", "10.3390/molecules25102301", "molecules25102301"]}}]}